Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Analysts Review
Editor Note: For more information about this release, please scroll to bottom.
NEW YORK, August 28, 2014 /PRNewswire/ --
Today, Analysts Review released its research reports regarding Intuitive Surgical, Inc. (NASDAQ: ISRG), Medivation, Inc. (NASDAQ: MDVN), Bed Bath & Beyond Inc. (NASDAQ: BBBY), Workday, Inc. (NYSE: WDAY) and Crown Castle International Corp. (NYSE: CCI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6036-100free.
Intuitive Surgical, Inc. Research Reports
On August 21, 2014, Intuitive Surgical, Inc. (Intuitive Surgical) announced that FDA has cleared the Firefly Fluorescence Imaging for its da Vinci® Xi™ Surgical System, which provides surgeons with enhanced visualization during minimally invasive surgical procedures. Intuitive Surgical informed that Firefly Imaging has been available since 2011 as an optional feature for the da Vinci® Si™ System. The latest FDI clearance paves way for the Company to ship Firefly Imaging with all da Vinci Xi Systems. According to Intuitive Surgical, this also marks the third major FDA clearance for products supporting the da Vinci Xi System since its U.S. launch in April 2014. The previous two clearances allowed Intuitive Surgical to market advanced technologies for vessel sealing and stapling for use with the da Vinci Xi System. Intuitive Surgical said that it will continue to seek regulatory clearances to market the da Vinci Xi System and its integrated technologies around the world. The full research reports on Intuitive Surgical are available to download free of charge at:
Medivation, Inc. Research Reports
On August 25, 2014, Medivation, Inc. (Medivation) announced that David Hung, M.D., President and CEO of the Company and CFO Rick Bierly, will present at the Morgan Stanley Healthcare Conference on September 8, 2014 at 9:20 AM ET at the Grand Hyatt, New York. Medivation informed that the live audio webcast of the presentation will be available at its investors website under events section. Additionally a replay of the webcast will be available on its website for 30 days. The full research reports on Medivation are available to download free of charge at:
Bed Bath & Beyond Inc. Research Reports
According to Bed Bath & Beyond Inc.'s (Bed Bath & Beyond) Investor Relations section, the Company will release its Q2 FY 2014 financial results on September 23, 2014. Bed Bath & Beyond will also hold its Q2 FY 2014 earnings conference call the same day at 5:00 p.m. ET. Analysts at Bloomberg Businessweek expect the Company's Q2 FY 2014 earnings at $1.14 per share, down from $1.16 per share in the corresponding quarter of previous fiscal year. The full research reports on Bed Bath & Beyond are available to download free of charge at:
Workday, Inc. Research Reports
On August 18, 2014, Workday, Inc. (Workday) announced the appointment of former IBM executive Randy Hendricks as President of Workday's Education and Government (E&G) business. According to the Company, this appointment highlights Workday's investment and momentum in its E&G business as more municipalities, state governments, non-profit, and higher education institutions look to the Company to transform and update their aging information systems. Workday informed that in this new role, Mr. Hendricks will report directly to Co-Founder and Chairman Dave Duffield, and will be responsible for sales, services, and strategy of HR, finance, and student applications for Workday's E&G customers. "Randy and I have worked closely together for many years, and I'm thrilled to add such an accomplished and respected leader in public sector to the Workday E&G team," said Dave Duffield, Co-Founder and Chairman, Workday. "He was a significant Workday advocate and partner at IBM, and his deep expertise, relationships, and industry vision will enhance Workday's leadership position in the rapidly emerging enterprise cloud applications market." The full research reports on Workday are available to download free of charge at:
Crown Castle International Corp. Research Reports
On August 25, 2014, the stock of Crown Castle International Corp. (Crown Castle) gained 0.10% to end the trading session at $79.56. Shares in Crown Castle opened at $79.70, and fluctuated in the range of $78.96 - $79.85, with a total of 1.43 million shares changing hands. The stock has gained 8.67% in the last one month, outperforming the Dow Jones Industrial Average which increased 0.69% during the same period. The full research reports on CrownCastle are available to download free of charge at:
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
©2012 PR Newswire. All Rights Reserved.